ECU
TVGN icon

Eisler Capital (UK)’s Tevogen Inc TVGN Stock Holding History

Eisler Capital (UK)’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,518
Closed -$2.76M – 291
2022
Q2 		$2.76M Buy
5,518
+4,825
+696% +$2.41M 0.09% 150
2022
Q1 		$346K Buy
+693
New +$345K 0.01% 421

Other funds holding TVGN

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Eisler Capital (UK)'s TVGN Position: Q3 2022 in Review

Eisler Capital (UK) sold out of Tevogen Inc (TVGN) in Q3 2022, closing a stake of 5,518 shares — an estimated $2.76M sold.

Eisler Capital (UK) first reported a position in TVGN in Q1 2022 and held it in 2 quarters. The position peaked at $2.76M in Q2 2022. 62 funds tracked by Wall St. Rank hold TVGN as of Q3 2022.

  • Eisler Capital (UK) reported no remaining Tevogen Inc position as of Q3 2022 after selling out during the quarter.
  • Eisler Capital (UK) sold 5,518 Tevogen Inc shares in Q3 2022, an estimated $2.76M.
  • Eisler Capital (UK) first reported a position in Tevogen Inc in Q1 2022 and held it in 2 quarters.
  • Eisler Capital (UK)'s Tevogen Inc position peaked at $2.76M in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Tevogen Inc as of Q3 2022.

Based on Eisler Capital (UK)'s 13F filing for Q3 2022, filed 14 Nov 2022.